Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA (hPGT)

Journal of Clinical Investigation

Volumn 98, Issue 5, 1996, Pages 1142-1149

  Lu, Run ^a   Kanai, Naoaki ^a   Bao, Yi ^a   Schuster, Victor L ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Renal Division   (United States)

Author keywords

biological transport; carrier proteins; molecular cloning; prostaglandins

Indexed keywords

CARRIER PROTEIN; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2; THROMBOXANE B2;

ARTICLE; COLON; CONTROLLED STUDY; HEART; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; MOLECULAR CLONING; OVARY; PLACENTA; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTATE; PROTEIN LOCALIZATION; SMALL INTESTINE; SPLEEN; TISSUE DISTRIBUTION;

EID: 0029739973     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118897     Document Type: Article

References (71)

1. Samuelsson, B. 1990. Prostaglandins and related compounds: Seventh International Conference, Florence, Italy. Adv. Prostaglandin Thromboxane Leukotriene Res. 21A-B, 1012 pp.
2. Murphy, R.C., and F.A. Fitzpatrick. 1990. Arachidimate related lipid mediators. Methods Enzymol. 187:1-683.
3. Bito, L.Z., and J. Stjernschantz. 1989. The Ocular Effects of Prostaglandins and Other Eicosanoids. Prog. Clin. Biol. Res. 312:1-514.
4. Segal, M.B. 1992. Barriers and Fluids of the Eye and Brain. CRC Press, Boca Raton, FL. 219 pp.
5. Levine, L. 1988. Arachidonate Metabolism in Immunologic Systems. Karger, New York, 214 pp.
6. Epstein, M. 1986. Prostaglandins and the kidney. Am. J. Med. 80:1-84.
7. Gugler, R., J.E. McGuigan, and K. Soderquist. 1986. Prostaglandins in the upper gastrointestinal tract: focus on misoprostol: proceedings of the second international symposium. Dig. Dis. Sci. 31(Suppl.):1-150.
8. Neri Serneri, G.G., J.C. McGiff, R. Paoletti, and G.V.R. Born. 1985. Platelets, prostaglandins, and the cardiovascular system. Adv. Prostaglandin Thromboxane Leukotriene Res. 13:1-393.
9. Quiroga, J., and J. Prieto. 1993. Liver cytoprotection by prostaglandins. Pharmacol. Therap. 58:67-91.
10. Ziai, N., J.W. Dolan, R.D. Kacere, and R.F. Brubaker. 1993. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes. Arch. Ophthalmol. 111:1351-1358.
11. Alm, A., J. Villumsen, P. Tornquist, A. Mandahl, J. Airaksinen, A. Tuulonen, B. Resul, and J. Stjernschantz. 1993. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study. Ophthalmology. 100:1312-1316.
12. Ulmann, A., L. Silvestre, L. Chemama, Y. Rezvani, M. Renault, C.J. Aguillaume, and E.E. Baulieu. 1992. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women. Acta Obstet. Gynecol. Scand. 71:278-283.
13. Konturek, S.J., N. Kwiecien, W. Obtulowicz, J. Maczka, Z. Hebzda, and J. Oleksy. 1991. Effects of nocioprost on gastric functions in man. Scand. J. Gastroenterol. 26:1145-1151.
14. Kobayashi, K., T. Arakawa, K. Higuchi, and H. Nakamura. 1991. Gastric cytoprotection by ornoprostil, a PGE1 analogue, in human subjects. J. Clin. Gastroenterol. 13 (Suppl. 1):S32-S36.
15. Bardhan, K.D., R. Walker, R.F. Hinchliffe, K. Bose, P. Morris, M. Thompson, E. Toivanen, R.P. Thompson, P. Patrier et al. 1991. Gastric ulcer healing: a comparison of enprostil versus ranitidine. J. Clin. Gastroenterol. 13: 157-162.
16. Roseman, T.J., and S.H. Yalkowsky. 1973. Physicochemical properties of prostaglandin F2 alpha (tromethamine salt): solubility behavior, surface properties, and ionization constants. J. Pharm. Sci. 62:1680-1685.
17. Uekama, K., F. Hirayama, H. Tanaka, and K. Takematsu. 1978. Partition behavior and ion pair formation of some prostaglandins. Chem. & Pharm. Bull. (Tokyo). 26:F58.
18. Bito, L.Z., and R.A. Baroody. 1975. Impermeability of rabbit erythrocytes to prostaglandins. Am. J. Physiol. 229:1580-1584.
19. Eling, T.E., and M.W. Anderson. 1976. Studies on the biosynthesis, metabolism and transport of prostaglandins by the lung. Agents Actions. 6:543-546.
20. Anderson, M.W., and T.E. Eling. 1976. Prostagiandin removal and metabolism by isolated perfused rat lung. Prostaglandins: 11:645-677.
21. Hawkins, H.J., A.G. Wilson, M.W. Anderson, and T.E. Eling. 1977. Uptake and metabolism of prostaglandins by isolated perfused lung: species comparisons and the role of plasma protein binding. Prostaglandins. 14:251-259.
22. Eling, T.E., H.J. Hawkins, and M.W. Anderson. 1977. Structural requirements for, and the effects of chemicals on, the rat pulmonary inactivation of prostaglandins. Prostaglandins. 14:51-60.
23. Bito, L.Z., and E.V. Salvador. 1976. Effects of anti-inflammatory agents and some other drugs on prostaglandin biotransport. J. Pharmacol. Exp. Ther. 198:481-488.
24. Bito, L.Z., H. Davson, and E.V. Salvador. 1976. Inhibition of in vitro concentrative prostaglandin accumulation by prostaglandins, prostaglandin analogues and by some inhibitors of organic anion transport. J. Physiol. (Lond). 256:257-271.
25. Bito, L.Z., and M.C. Wallenstein. 1977. Transport of prostaglandins across the blood-brain and blood-aqueous barriers and the physiological significance of these absorptive transport processes. Exp. Eye. Res. 25 (Suppl):229-243.
26. Hagen, A.A., J.N. Gerber, C.C. Sweeley, R.P. White, and J.T. Robertson. 1977. Levels and disappearance of prostaglandin F2alpha in cerebral spinal fluid: a clinical and experimental study. Stroke. 8:672-675.
27. DiBenedetto, F.E., and L.Z. Bito. 1986. Transport of prostaglandins and other eicosanoids by the choroid plexus: its characterization and physiological significance. J. Neurochem. 46:1725-1731.
28. Suzuki, F., H. Hayashi, and O. Hayashi. 1986. Transport of prostaglandin D2 into brain. Brain Res 385:321-328.
29. Bikhazi, A.B., G.M. Baasiri, N.Z. Boulos, and R.N. Khuri. 1983. Transport of prostaglandins through normal and diabetic rat hepatocytes. J. Pharm. Sci. 72:296-299.
30. Bito, L.Z. 1973. Absorptive transport of prostaglandins from intraocular fluids to blood: a review of recent findings. Exp. Eye Res. 16:299-306.
31. Bito, L.Z. 1975. Saturable, energy-dependent, transmembrane transport of prostaglandins against concentration gradients. Nature (Lond.). 256:134-136.
32. Jones, M.A., and M.J. Harper. 1983. Prostaglandin accumulation by isolated uterine endometrical epithelial cells from six-day pregnant rabbits. Biol. Reprod. 29:1201-1209.
33. Cao, Z.D., M.A. Jones, and M.J. Harper. 1984. Prostaglandin translocation from the lumen of the rabbit uterus in vitro in relation to day of pregnancy or pseudopregnancy. Biol. Reprod. 31:505-519.
34. Walenga, R.W., D.C. Kuhn, and M.J. Stuart. 1989. Trans-placental transport and metabolism of carbacyclin by perfused human placental in vitro. Prostaglandins. 37:121-134.
35. McCoshen, J.A., D.R. Hoffman, J.V. Kredentser, C. Araneda, and J.M. Johnston. 1990. The role of fetal membranes in regulating production, transport, and metabolism of prostaglandin E2 during labor. Am. J. Obstet. Gynecol. 163:1632-1640.
36. Kanai, N., R. Lu, J. Satriano, Y. Bao, A.W. Wolkoff, and V.L. Schuster. 1995. Identification and characterization of a prostaglandin transporter. Science (Wash. DC). 268:866-869.
37. Morita, I., W.L. Smith, D.L. DeWilt, and M. Schindler. 1995. Expression-activity profiles of cells transfected with prostaglandin endoperoxide H synthase measured by quantitative fluorescence microscopy. Biochemistry. 34: 7194-7199.
38. Ferreira, S.H., and J.R. Vane. 1967. Prostaglandins: their disappearance from and release into the circulation. Nature (Lond.). 216:868-873.
39. Irish, J.M. 1979. Secretion of prostaglandin E2 by rabbit proximal tubules. Am. J. Physiol. 237:F268-F273.
40. McGiff, J.C., N.A. Terragno, J.C. Strand, J.B. Lee, A.J. Lonigro, and K.K. Ng. 1969. Selective passage of prostaglandins across the lung. Nature (Lond). 223:742-745.
41. Piper, P.J. J.R. Vane, and J.H. Wyllie. 1970. Inactivation of prostaglandins by the lungs. Nature (Lond). 225:600-604.
42. Moncada, S., R. Korbut, S. Bunting, and J.R. Vane. 1978. Prostacyclin is a circulating hormone. Nature (Lond). 273:767-768.
43. Dusting, G.J., S. Moncada, and J.R. Vane. 1978. Recirculation of prostacyclin (PGI2) in the dog. Br. J. Pharmacol. 64:315-320.
44. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 10.13-10.17.
45. Fuerst, T.R., E.G. Niles, F.W. Studier, and B. Moss. 1986. Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:8122-8126.
46. Neame, K.D., and T.G. Richards. 1972. Elementary Kinetics of Membrane Carrier Transport. John Wiley & Sons, New York. 120 pp.
47. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
48. Kozak, M. 1991. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol. 115:887-903.
49. Kyte, J., and R.F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
50. +-independent organic anion transporter. Proc. Natl. Acad. Sci. USA. 91:133-137.
51. Kanai, N., R. Lu, Y. Bao, A.W. Wolkoff, M. Vore, and V.L. Schuster. 1996. Estradiol 17-β D-glucuronide is a high-affinity substrate for the organic anion transporter "oatp." Am. J. Physiol. (Renal Fluid Electrolyte Physiol) 270: F326-F331.
52. Glance, D.G., M.G. Elder, and L. Myatt. 1986. Uptake, transfer and metabolism of prostaglandin E2 in the isolated perfused human placental cotyledon. Prostaglandins Leuko. Med. 21:1-14.
53. von Euler, U.S., and R. Eliasson. 1967. Prostaglandins. Academic Press, New York. 164 pp.
54. Zusman, R.M., D. Spector, B.V. Caldwell, L. Speroff, G. Schneider, and P.J. Mulbow. 1973. The effect of chronic sodium loading and sodium restriction on plasma prostaglandin A, E, and F concentrations in normal humans. J. Clin. Invest. 52:1093-1098.
55. Neri Serneri, G.G., G.F. Gensini, R. Abbate, D. Prisco, P.G. Rogasi, G.C. Casolo, M. Matucci, F. Fantini, M. Di Donato, and F.P. Dabizzi. 1985. Spontaneous and cold pressor test-induced prostaglandin biosynthesis by human heart. Am. Heart J. 110:50-55.
56. Neri Serneri, G.G., G.F. Gensini, R. Abbate, D. Prisco, P.G. Rogasi, G.C. Casolo, A. Fazi, F. Fantini, M. Di Donato et al. 1986. Impaired cardiac PGI2 and PGE2 biosynthesis in patients with angina pectoris. Am. Heart J. 112: 472-478.
57. Nowak, J., L. Kaijser, and A. Wennmalm. 1980. Cardiac prostaglandin formation in man. Adv. Myocardiology. 1:323-328.
58. Hirsh, P.D., L.D. Hillis, W.B. Campbell, B.G. Firth, and J.T. Willerson. 1981. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N. Engl. J. Med. 304:685-691.
59. Sri Kantha, S., H. Matsumura, E. Kubo, K. Kawase, R. Takahata, and C.N. Serhan. 1994. Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats. Prostaglandins. Leukot. Essent. Fatty Acids. 51:87-93.
60. Ito, S., S. Narumiya, and O. Hayaishi. 1989. Prostaglandin D2: a biochemical perspective. Prostaglandins Leukot. Essent. Fatty Acids. 37:219-234.
61. Matsumura, H., T. Nakajima, T. Osaka, S. Satoh, K. Kawase, E. Kubo, S.S. Kantha, K. Kasahara, and O. Hayaishi. 1994. Prostaglandin D2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc. Natl. Acad. Sci. USA. 91:11998-12002.
62. Hayaishi, O. 1991. Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E2. FASEB. J. 5:2575-2581.
63. Matsumura, K., Y. Watanabe, K. Imai-Matsumura, M. Connolly, Y. Koyama, and H. Onoe. 1992. Mapping of prostaglandin E2 binding sites in rat brain using quantitative autoradiography. Brain Res. 581:292-298.
64. Cayeux, S.J., P.C. Beverley, R. Schulz, and B. Dorken. 1993. Elevated plasma prostaglandin E2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation. Bone Marrow Transplant. 12:603-608.
65. Seyberth, H.W., W. Rascher, H. Schweer, P.G. Kuhl, O. Mehls, and K. Scharer. 1985. Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J. Pediatr. 107:694-701.
66. Seyberth, H.W., S.J. Koniger, W. Rascher, P.G. Kuhl, and H. Schweer. 1987. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr. Nephrol. 1:491-497.
67. Camras, C.B., R.A. Schumer, A. Marsk, J.S. Lustgarten, J.B. Serie, L.Z. Bito, and S.M. Podos. 1992. Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension. Arch. Ophthalmol. 110:1733-1738.
68. Wolfson, B., S. Pickett, N.E. Scott, J.B. DeKernion, and J. Rajfer. 1993. Intraurethral prostaglandin E-2 cream: a possible alternative treatment for erectile dysfunction. Urology. 42:73-75.
69. Karim, A., L.F. Rozek, M.E. Smith, and K.G. Kowalski. 1989. Effects of food and antacid on oral absorption of misoprostol, a synthetic prostaglandin E1 analog. J. Clin. Pharmacol. 29:439-443.
70. Hesse, W.H., G. Rudofsky, and B. A. Peskar. 1991. Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease. Klin. Wochenschr. 103:554-557.
71. Cawello, W., H. Schweer, R. Muller, R. Bonn, and H.W. Seyberth. 1994. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects. Eur. J. Clin. Pharmacol. 46:275-277.